A comprehensive industry examination reveals what manufacturer disclosures, clinical study documentation, and delivery system ...

Immunotherapy has emerged in recent years as a new cancer treatment that is gentler than traditional chemotherapy and causes ...

Register Free: https://www.appliedclinicaltrialsonline.com/act_w/trial-workflows ...

The 2025 Community Oncology Conference, hosted by COA, reflected a commitment to patient-centered care, access, and ...

Intestinal Stem Cells (ISCs) derived from a patient's own cells have garnered significant attention as a new alternative for treating intractable intestinal diseases due to their low risk of rejection ...

Cancer has long remained a leading cause of death worldwide and in Hong Kong, accounting for 30% of all disease-related deaths in the city in 2025. While chemotherapy remains a major treatment ...

China, by contrast, is pursuing a state-led coordinated approach that integrates policy planning, clinical validation, and ...

The clinical trial industry is at a critical juncture where traditional methods are proving insufficient for managing today’s ...

The request for information comes as the Trump administration has largely taken a deregulatory stance on AI, in a bid to ...

OneOncology supports 33 practices, providing infrastructure and expertise for advanced therapies and value-based care, while ...

Health IT’s Legacy and the Road to Responsible AI by Dr. S. Yin Ho is an indispensable book about the current state of health information technology and how responsible AI could reshape our U.S.

To my colleagues in academic medicine: The ACGME should mandate AI competency standards by 2026. Medical licensing boards ...